Biomembrane Permeation of Nicotine: Mechanistic Studies with Porcine Mucosae and Skin
- 1 February 1997
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (2), 257-262
- https://doi.org/10.1021/js960095w
Abstract
In the present study, the permeation and partitioning of nicotine as a function of pH was investigated with various regions of skin and absorptive mucosae that were freshly excised from domestic pigs. As an ionizable compound (pKa values of 3.04 and 7.84), nicotine in solutions of different pH values provides a model for determining the influence of the charge status of a molecule on permeation. The permeation of nicotine across porcine mucosae and skin followed zero-order kinetics. The rate of permeation was dependent on donor solution pH and increased exponentially as the pH increased. With an exception of the nasal mucosa, which showed similar permeabilities for all species of nicotine, the permeability of nicotine across various skin and mucosal specimens was significantly higher (p < 0.001) for the un-ionized species (NN) than for the ionized species (NNH+, NH+NH+). It was also seen that un-ionized nicotine molecules were more permeable through absorptive mucosae (nasal, buccal, sublingual, and gingival) than through skin (abdominal, dorsal, thigh, and ear pinna). Partition studies were performed and the results further confirmed that biomembrane permeation of nicotine follows the pH-partition theory.Keywords
This publication has 26 references indexed in Scilit:
- Development of a new nicotine transdermal delivery system: in vitro kinetics studies and clinical pharmacokinetic evaluations in two ethnic groupsJournal of Controlled Release, 1993
- Controlled dosing of nicotine via anIntranasalNicotineAerosolDeliveryDevice (INADD)Psychopharmacology, 1992
- Nasal nicotine spray: a rapid nicotine delivery systemPsychopharmacology, 1992
- Randomised controlled trial of nasal nicotine spray in smoking cessationThe Lancet, 1992
- Methods of smoking cessationMedical Clinics of North America, 1992
- Pharmacokinetics of Multiple Daily Transdermal Doses of Nicotine in Healthy SmokersPharmaceutical Research, 1991
- Nicotine-Replacement Therapy With Use of a Transdermal Nicotine Patch—a Randomized Double-Blind Placebo-Controlled TrialMayo Clinic Proceedings, 1990
- CONTROLLED TRIAL OF TRANSDERMAL NICOTINE PATCH IN TOBACCO WITHDRAWALThe Lancet, 1989
- Randomised controlled trial of nicotine chewing-gum.BMJ, 1982
- Nicotine chewing gum as a substitute for smoking.BMJ, 1977